2012•Zhonghua neifenmi daixie zazhiRequires access

Early usage of liraglutide with benefits in type 2 diabetes

Changyu Pan

Open publisher page 0 citations

Abstract

With the progress of type 2 diabetes,there are more challenges for treatment.Traditional medications may not meet type 2 diabetes complicated clinical needs.Glucagon like peptide-1 ( GLP-1 ) has multiple physiological effects.Studies show that the liraglutide as the native GLP-1 analogue provides well glucose control in different stages of type 2 diabetes treatment,as well as β cell protection,body weight decrease and the prevalence of prediabetes reduction.Early usage of liraglutide especially suggests significant benefits,which will be summarized below. Key words: Diabetes mellitus, type 2 ;  Glucagon-like peptide-1 ;  Liraglutide

About this research paper

What this paper is about

With the progress of type 2 diabetes,there are more challenges for treatment.Traditional medications may not meet type 2 diabetes complicated clinical needs.Glucagon like peptide-1 ( GLP-1 ) has multiple physiological effects.Studies show that the liraglutide as the native GLP-1 analogue provides well glucose control in different stages of type 2 diabetes treatment,as well as β cell protection,body weight decrease and the prevalence of prediabetes reduction.Early usage of liraglutide especially suggests significant benefits,which will be summarized below. Key words: Diabetes mellitus, type 2 ;  Glucagon-like peptide-1 ;  Liraglutide

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

With the progress of type 2 diabetes,there are more challenges for treatment.Traditional medications may not meet type 2 diabetes complicated clinical needs.Glucagon like peptide-1 ( GLP-1 ) has multiple physiological effects.Studies show that the liraglutide as the native GLP-1 analogue provides well glucose control in different stages of type 2 diabetes treatment,as well as β cell protection,body weight decrease and the prevalence of prediabetes reduction.Early usage of liraglutide especially suggests significant benefits,which will be summarized below. Key words: Diabetes mellitus, type 2 ;  Glucagon-like peptide-1 ;  Liraglutide

Key concepts: Liraglutide, Prediabetes, Medicine, Type 2 diabetes, Diabetes mellitus, Glucagon-like peptide-1, Internal medicine, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Early usage of liraglutide with benefits in type 2 diabetes — Research Paper | ScholarLens